Sign in
4

Changes in Ownership

Tyra Biosciences, Inc. Filed Acc 0001209191-23-022432

Chief Operating Officer sold 4,400 shares at an average $16.07 ($70,729)

  • Chief Operating Officer acquired 4,400 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Bensen Daniel Chief Operating Officer 2023-03-30 Option exercise 10b5-1 +2,000 $0.61 $1,220 529,981 D
Bensen Daniel Chief Operating Officer 2023-03-30 Sale 10b5-1 −2,000 $16.01 $32,015 527,981 D
Bensen Daniel Chief Operating Officer 2023-03-31 Option exercise 10b5-1 +400 $0.61 $244 528,381 D
Bensen Daniel Chief Operating Officer 2023-03-31 Sale 10b5-1 −400 $16.00 $6,400 527,981 D
Bensen Daniel Chief Operating Officer 2023-04-03 Option exercise 10b5-1 +2,000 $0.61 $1,220 529,981 D
Bensen Daniel Chief Operating Officer 2023-04-03 Sale 10b5-1 −2,000 $16.16 $32,314 527,981 D
Derivatives
Bensen Daniel Chief Operating Officer 2023-03-30 Option exercise · Stock Option (Right to Buy) 10b5-1 −2,000 231,821 D
Bensen Daniel Chief Operating Officer 2023-03-31 Option exercise · Stock Option (Right to Buy) 10b5-1 −400 231,421 D
Bensen Daniel Chief Operating Officer 2023-04-03 Option exercise · Stock Option (Right to Buy) 10b5-1 −2,000 229,421 D
Open-market sales · 4,400 sh · avg $16.07 · $70,729
Loading xslF345X04/doc4.xml…